ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

FECH Expression Correlates with the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma

Zhong, Guanghui; Li, Qing; Luo, Yang; Liu, Yufeng; Liu, Dawei; li, Bin; Wang, Tao*南方医科大学; 5
Journal of Oncology2022-8-25DOI: 10.1155/2022/8943643
1被引14阅读
引用收藏
分享

摘要

Background. Clear cell renal cell carcinoma (ccRCC) is, by far, the most prevalent and fatal kind of kidney cancer. Ferrochelatase (FECH) is an enzyme that performs a significant function in the onset and progression of many distinct kinds of malignant tumors. Nevertheless, its predictive usefulness in renal clear cell carcinoma (RCC) has not yet been fully investigated. Methods. FECH expression in ccRCC and healthy adjoining tissues was primarily screened utilizing data sourced from The Cancer Genome Atlas (TCGA) and subsequently validated using data from an independent cohort derived from the Gene Expression Omnibus (GEO) and the Human Protein Atlas HPA databases. The relationship among FECH expression, clinicopathological parameters, and overall survival (OS) was assessed utilizing multivariate analysis and Kaplan-Meier survival curves. Additionally, the protein networks with FECH interaction were constructed with the aid of the online Search Tool for the Retrieval of Interacting Genes/Proteins (STRING). Gene ontology (GO) analysis, and gene set enrichment analysis (GSEA) were conducted based on TCGA data, and a single-sample GSEA was utilized to explore the link between FECH expression and the infiltration status of immune cells in the tumor. The Gene Expression Profiling Interactive Analysis (GEPIA) and TIMER databases were utilized to investigate the relationships of FECH expression with the infiltrating immune cells and the matching gene marker sets. Results. FECH expression was shown to be substantially lowered in ccRCC tumors as opposed to that observed in normal tissues (p < 0.05). Lower levels of FECH expression were shown to have a strong association with higher grades of cancer and more advanced TNM stages. The findings of multivariate and univariate analyses illustrated that the OS in patients with ccRCC with low FECH expression is shorter in contrast with that in the high FECH expression group (p < 0.05). It was discovered that CPOX and frataxin are key proteins that interact with FECH. ccRCC with FECH deficiency was linked to the lack of infiltrating immune cells and their respective marker sets, which included CD4+ T cells. Conclusion. In ccRCC, decreased FECH expression was linked to disease progression, unfavorable prognosis, and impaired immune cell infiltration.

学科与关键词

关键词
PROTOPORPHYRIN-IX ACCUMULATION5-AMINOLEVULINIC ACIDPHOTODYNAMIC THERAPYCANCER-CELLSFERROCHELATASEFLUORESCENCEGENEEXPOSUREPATHWAY
相关
加载中…
  • Cuproptosis-related gene FDX1 expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma
    Wang, Tao*; Liu, Yufeng; Li, Qing; Luo, Yang; Liu, Dawei; Li, BinFrontiers in Immunology, 2022, 13: 999823.被引 22
  • Decreased CDKL2 Expression in Clear Cell Renal Cell Carcinoma Predicts Worse Overall Survival
    Chen, Zhan; Lv, Yan; He, Lu; Wu, Shunli; Wu, Zhuang*Frontiers in Molecular Biosciences, 2022, 8: 657672.被引 2
  • High Hepcidin expression predicts poor prognosis in patients with clear cell renal cell carcinoma
    Tang, Yuting; Ge, Shengdong; Zheng, Xiao*; Zheng, Jiejiao*Diagnostic Pathology, 2022, 17(1): 100.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Oncology
发表日期
2022-08-25
卷期
第 2022 卷
页码
8943643
DOI
10.1155/2022/8943643
期刊等级
4区
成果收录
SCIE
资助标注
Natural Science Foundation of Guangdong Province; [2020A1515010141]

作者

  • Z

    Zhong, Guanghui (第一作者)

    5 · southern med univ

  • L

    Li, Qing

    5 · southern med univ

查看全部 7 位作者收起作者
  • L

    Luo, Yang

    5 · southern med univ

  • L

    Liu, Yufeng

    5 · southern med univ

  • L

    Liu, Dawei

    5 · southern med univ

  • l

    li, Bin

    5 · southern med univ

  • W

    Wang, Tao (通讯)

    5 · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417